BIOMAT Database Logo BIOMAT Database Logo

Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors. 2017

Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Nano Science and Technology Institute, University of Science and Technology of China, Suzhou 215123, China.

Three series of pyrazolo[3,4-d]pyrimidine derivatives were synthesized and evaluated as RET kinase inhibitors. Compounds 23a and 23c were identified to show significant activity both in the biochemical and the BaF3/CCDC6-RET cell assays. Compound 23c was found to significantly inhibit RET phosphorylation and down-stream signaling in BaF3/CCDC6-RET cells, confirming its potent cellular RET-targeting profile. Different from other RET inhibitors with equal potency against KDR that associated with severe toxicity, 23c did not show significant KDR-inhibition even at the concentration of 1μM. These results demonstrated that 23c is a potent and selective RET inhibitor.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors.
November 2020, Molecules (Basel, Switzerland),
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors.
May 2003, European journal of medicinal chemistry,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
February 2008, Bioorganic & medicinal chemistry letters,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
October 1996, Journal of medicinal chemistry,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Synthesis and biological evaluation of xanthine oxidase inhibitors. Pyrazolo(3,4-d)pyrimidines and pyrazolo(3,4-b)pyridines.
February 1975, Journal of medicinal chemistry,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
May 2004, Bioorganic & medicinal chemistry letters,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.
January 2024, Bioorganic & medicinal chemistry,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 3. Synthesis and activity of some nucleosides of 4-[(arylalkenyl)thio]pyrazolo[3,4-d]pyrimidines.
October 1983, Journal of medicinal chemistry,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Pyrazolo[3,4-d]pyrimidines as adenosine antagonists.
May 1984, Life sciences,
Chengyan Wang, and Hongchun Liu, and Zilan Song, and Yinchun Ji, and Li Xing, and Xia Peng, and Xisheng Wang, and Jing Ai, and Meiyu Geng, and Ao Zhang
Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines.
January 1982, Journal of medicinal chemistry,
Copied contents to your clipboard!